Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Incipient Schizophrenia

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Incipient Schizophrenia in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Van Dam, NT1
Earleywine, M1
DiGiacomo, G1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Incipient Schizophrenia

ArticleYear
Polydrug use, cannabis, and psychosis-like symptoms.
    Human psychopharmacology, 2008, Volume: 23, Issue:6

    Topics: Adult; Central Nervous System Stimulants; Cognition; Female; Humans; Male; Marijuana Abuse; N-Methyl

2008